# Rila reviews (2026): GLP-1 telehealth sellers | This GLP Rila names its medical group and pharmacy partners and describes check-ins during the first month. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/rila Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated October 2026 Medical group and pharmacies identified # Rila review Rila names its medical group and pharmacy partners and describes check-ins during the first month. ## The verdict Rila provides more specific first-month expectations and names its medical and pharmacy partners; clarify how that relationship continues after the first refill. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection · Oral Prescription Required Compounded Yes — not FDA-approved Rila offers online weight-management care with compounded GLP-1 injections and dissolving tablets. Its public timeline describes evaluation, treatment delivery and provider check-ins during the first month. 1. ## Who writes the prescription, and what do they see? The FAQ identifies Dr. TelX as an independent medical group. Providers licensed where care is offered make eligibility and prescribing decisions. Treatment is not guaranteed solely by completing the assessment. Rila’s first-month timeline places provider check-ins in weeks three and four, with support between refills. Ask whether those are scheduled clinical contacts and how monitoring changes once the initial plan is established. 2. ## What happens when the dose goes up? The timeline describes provider-directed adjustments as the patient responds. Confirm the formulation, milligram dose and reassessment process before comparing a tablet plan with an injection plan. 3. ## What the price includes Homepage starting equivalents require a six-month commitment. The terms say subscriptions renew until canceled and direct patients to a separate refund policy. A headline commitment price does not establish the upfront total or a refund for an already prepared shipment. 4. ## What it claims, and what it cites The site names [semaglutide](https://thisglp.com/research/semaglutide-cochrane-review) and [tirzepatide](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) and identifies EPIQ Scripts, Foothills Professional Pharmacy and Emerald Pharmacy as partners. The actual prescription can use a particular pharmacy from that network. Compounded preparations are not FDA-approved. ## Where it holds up, and where it does not - Strength: Medical group and pharmacies identified - Strength: Early check-in timeline described - Strength: Injection and oral categories are distinguished - Limitation: Headline figures require six months - Limitation: Continuing appointment cadence needs confirming - Limitation: Separate refund policy determines existing-order rights ## What the evidence says about this kind of treatment The assessment above is about Rila. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for Someone who wants an identified clinical network and a described early follow-up path before starting compounded treatment. Wrong for Someone who wants the lowest advertised equivalent without a six-month commitment. ## The evidence behind what Rila prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How Rila compares | Seller | Who it suits | Go | | --- | --- | --- | | SkinnyRx | Readers choosing tirzepatide, the one line with a published standing rate | | | ShedRx | Readers willing to telephone a seller and ask which published fee is the real one | | | RxSpan MD | Buyers who want the standing rate, the pharmacy and the prescriber named before signing up | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [Lyfe Rx](https://thisglp.com/reviews/lyfe-rx) [MadeMed](https://thisglp.com/reviews/mademed) [MANÜ Telehealth](https://thisglp.com/reviews/manu-telehealth) [Marek Health](https://thisglp.com/reviews/marek-health) [Maves](https://thisglp.com/reviews/maves) [Maximus](https://thisglp.com/reviews/maximus-tribe) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked What should I confirm about ongoing care? Rila’s first-month timeline places provider check-ins in weeks three and four, with support between refills. Ask whether those are scheduled clinical contacts and how monitoring changes once the initial plan is established. Ask who makes clinical decisions between refills and how to reach that person. Is a prescription guaranteed? No. An independent licensed clinician must decide whether treatment is appropriate; a product page or completed intake does not establish eligibility. ## Sources for this review Provider information checked October 26, 2026. Terms can change. - [Programs and first-month care](https://www.joinrila.com/) - [Pharmacy and medical-group FAQ](https://www.joinrila.com/faq) - [Subscription terms](https://www.joinrila.com/terms-of-service) Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).